Related Experiment Video
Updated: Jun 24, 2026

An Improved Method for Rapid Intubation of the Trachea in Mice
Published on: February 22, 2016
Newer agents for rapid sequence intubation: etomidate and rocuronium
1Section of Pediatric Emergency Medicine, Department of Pediatrics, Yale-New Haven Children's Hospital, Yale University School of Medicine, New Haven, CT 06504, USA.
Insights
Etomidate and rocuronium are effective sedating and paralyzing agents for pediatric rapid sequence intubation, offering rapid onset and minimal hemodynamic effects. However, etomidate
Area of Science:
- Pediatric Emergency Medicine
- Anesthesiology
- Critical Care
Background:
- Rapid sequence intubation (RSI) is crucial for emergency airway management in critically ill children and adolescents.
- Etomidate and rocuronium are increasingly utilized for sedation and neuromuscular blockade during pediatric RSI.
- Both agents offer advantages such as rapid onset and favorable hemodynamic profiles.
Purpose of the Study:
- To review the safety and efficacy of etomidate and rocuronium in pediatric RSI.
- To highlight the benefits and potential controversies surrounding their use.
Main Methods:
- Literature review of existing evidence on etomidate and rocuronium in pediatric RSI.
- Analysis of pharmacokinetic and pharmacodynamic properties.
- Evaluation of adverse effects and contraindications.
Main Results:
- Etomidate and rocuronium provide rapid onset of action and are generally well-tolerated hemodynamically.
- Rocuronium offers effective intubating conditions, avoiding succinylcholine-related complications.
- Etomidate's adrenal suppression raises concerns, particularly in pediatric septic shock cases.
Conclusions:
- Current evidence supports the safety of etomidate and rocuronium for pediatric RSI.
- Further prospective studies are warranted to solidify their role and address specific patient populations, like those with septic shock.
Abstract:
The emergency airway management of children and adolescents with critical illnesses may necessitate rapid sequence intubation with a sedating and a neuromuscular blocking agent. Etomidate and rocuronium have become increasingly popular for the sedation and paralysis, respectively, of pediatric patients in rapid sequence intubation, and there are many advantages to the use of both agents. Both etomidate and rocuronium have a rapid onset of action, and both agents are relatively free of hemodynamic adverse effects. Etomidate does, however, suppress adrenal function, and consequently, its use in patients with septic shock is controversial. Rocuronium can produce optimal intubating conditions without the serious complications that can accompany succinylcholine. The available evidence supports the safety of etomidate and rocuronium in rapid sequence intubation but also suggests that more prospective studies are needed in pediatric patients.
Related Concept Videos
Parenteral Anesthetics: Overview
Skeletal Muscle Relaxants: Therapeutic Uses
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Inhalational Anesthetics: Overview
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...

